News Âé¶¹´«Ã½ from Wren Laboratories Latest news from Wren Laboratories on News en-us Copyright 2025 News News Âé¶¹´«Ã½ from Wren Laboratories 115 31 / /images/newswise-logo-rss.gif Wren Laboratories Receives NYSDOH-CLEP Approval for PROSTest(tm), Transforming Prostate Cancer Detection /articles/wren-laboratories-receives-nysdoh-clep-approval-for-prostest-transforming-prostate-cancer-detection/?sc=rsin /articles/wren-laboratories-receives-nysdoh-clep-approval-for-prostest-transforming-prostate-cancer-detection/?sc=rsin Fri, 25 Apr 2025 10:20:39 EST Wren Laboratories, a leader in molecular diagnostics, is proud to announce that its breakthrough liquid biopsy test, PROSTest(tm), has been approved by the New York State Department of Health Clinical Laboratory Evaluation Program (NYSDOH-CLEP). Wren Laboratories Wren Laboratories Unveils Dynamic Executive Leadership Team and 2024 Commercial Strategy Overhaul /articles/wren-laboratories-unveils-dynamic-executive-leadership-team-and-2024-commercial-strategy-overhaul/?sc=rsin /articles/wren-laboratories-unveils-dynamic-executive-leadership-team-and-2024-commercial-strategy-overhaul/?sc=rsin Thu, 13 Jun 2024 11:15:55 EST Wren Laboratories announced executive leadership for commercial operations and market expansion. Dr. Abdel Halim is appointed CEO and CSO. Troy Tremaine Appointed to CCO, Dr. Eva Szarek Head of Marketing, and Melissa Ferone director of quality. Expansion includes AI-driven mRNA liquid biopsy genomic assays for biopharma and diagnostics. Wren Laboratories Wren Laboratories adds Clinical Relations and Regulatory Compliance Expertise to its Expanding Team /articles/wren-laboratories-adds-clinical-relations-and-regulatory-compliance-expertise-to-its-expanding-team/?sc=rsin /articles/wren-laboratories-adds-clinical-relations-and-regulatory-compliance-expertise-to-its-expanding-team/?sc=rsin Fri, 19 Jan 2024 13:05:41 EST Wren Laboratories is pleased to announce the addition of Dr. Mark Harman, MD, MBA, MS, BCMAS, as a Clinical Consultant for the 10-year-old molecular diagnostic company. Wren Laboratories Wren Laboratories Dr. Mark Kidd to speak at 2024 Precision Medicine World Conference /articles/wren-laboratories-dr-mark-kidd-to-speak-at-2024-precision-medicine-world-conference/?sc=rsin /articles/wren-laboratories-dr-mark-kidd-to-speak-at-2024-precision-medicine-world-conference/?sc=rsin Fri, 19 Jan 2024 09:05:08 EST The presentation will focus on the use of mRNA in Liquid Biopsies as a platform for precision diagnostics Wren Laboratories Wren Laboratories Expands Flagship Molecular Cancer Diagnostic NETest to China /articles/wren-laboratories-expands-flagship-molecular-cancer-diagnostic-netest-to-china/?sc=rsin /articles/wren-laboratories-expands-flagship-molecular-cancer-diagnostic-netest-to-china/?sc=rsin Tue, 17 Oct 2023 11:05:48 EST Licensing agreement with Kindstar Globalgene Technology will more than double Wren NETest distribution within first year Wren Laboratories Wren Laboratories' NETest leverages mRNA and Artificial Intelligence to create highly accurate, personalized neuroendocrine cancer diagnostics /articles/wren-laboratories-netest-leverages-mrna-and-artificial-intelligence-to-create-highly-accurate-personalized-neuroendocrine-cancer-diagnostics/?sc=rsin /articles/wren-laboratories-netest-leverages-mrna-and-artificial-intelligence-to-create-highly-accurate-personalized-neuroendocrine-cancer-diagnostics/?sc=rsin Tue, 17 Oct 2023 10:05:41 EST Blood-based molecular NET cancer test delivers accuracy and specificity levels unsurpassed by other diagnostic methods Wren Laboratories